These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 21034746
21. Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells. Shyam H, Singh N, Kaushik S, Sharma R, Balapure AK. Apoptosis; 2017 Apr; 22(4):570-584. PubMed ID: 28176146 [Abstract] [Full Text] [Related]
22. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Upadhyay S, Neburi M, Chinni SR, Alhasan S, Miller F, Sarkar FH. Clin Cancer Res; 2001 Jun; 7(6):1782-9. PubMed ID: 11410520 [Abstract] [Full Text] [Related]
23. Polyphenols sensitization potentiates susceptibility of MCF-7 and MDA MB-231 cells to Centchroman. Singh N, Zaidi D, Shyam H, Sharma R, Balapure AK. PLoS One; 2012 Jun; 7(6):e37736. PubMed ID: 22768036 [Abstract] [Full Text] [Related]
24. Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells. Jun SY, Choi YH, Shin HM. Oncol Rep; 2006 Jun; 15(6):1461-7. PubMed ID: 16685380 [Abstract] [Full Text] [Related]
25. Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis. Kaushik S, Shyam H, Agarwal S, Sharma R, Nag TC, Dwivedi AK, Balapure AK. Life Sci; 2019 Dec 15; 239():117073. PubMed ID: 31751581 [Abstract] [Full Text] [Related]
26. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Kim JB, Lee KM, Ko E, Han W, Lee JE, Shin I, Bae JY, Kim S, Noh DY. Planta Med; 2008 Jan 15; 74(1):39-42. PubMed ID: 18203057 [Abstract] [Full Text] [Related]
27. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, Lin JP, Tang NY, Chung JG, Chou MJ, Teng YH, Chen DR. Arch Pharm Res; 2010 Aug 15; 33(8):1181-91. PubMed ID: 20803121 [Abstract] [Full Text] [Related]
28. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A, Castle VP, Bouziane M, Bhalla K, Haldar S. Cancer Res; 2006 Apr 15; 66(8):4309-18. PubMed ID: 16618756 [Abstract] [Full Text] [Related]
29. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC. Cancer Res; 2005 Jun 01; 65(11):4799-808. PubMed ID: 15930300 [Abstract] [Full Text] [Related]
30. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer. Girault I, Bièche I, Lidereau R. Maturitas; 2006 Jul 20; 54(4):342-51. PubMed ID: 16822624 [Abstract] [Full Text] [Related]
31. [Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative]. Jing J, Zheng H, Wang J, Lin P, Zhang J, Xiong ZJ, Wu YY, Ren JJ, Yang HL, Wang XJ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 20; 38(3):391-5. PubMed ID: 17593814 [Abstract] [Full Text] [Related]
32. Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer. Khan S, Shukla S, Sinha S, Meeran SM. Mol Carcinog; 2016 Nov 20; 55(11):1747-1760. PubMed ID: 26465660 [Abstract] [Full Text] [Related]
33. Anticlastogenic effects of centchroman and its enantiomers in Swiss albino mice. I. Acute study and their comparison with tamoxifen. Mukhopadhyay A, Gupta S, Ray S, Giri AK. Cancer Lett; 1999 Oct 01; 144(2):137-43. PubMed ID: 10529013 [Abstract] [Full Text] [Related]
34. Genistein synergizes centchroman action in human breast cancer cells. Kaushik S, Shyam H, Sharma R, Balapure AK. Indian J Pharmacol; 2016 Oct 01; 48(6):637-642. PubMed ID: 28066099 [Abstract] [Full Text] [Related]
35. Design, synthesis, and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy. Sreekanth V, Bansal S, Motiani RK, Kundu S, Muppu SK, Majumdar TD, Panjamurthy K, Sengupta S, Bajaj A. Bioconjug Chem; 2013 Sep 18; 24(9):1468-84. PubMed ID: 23909664 [Abstract] [Full Text] [Related]
36. Resveratrol as an adjunct therapy in cyclophosphamide-treated MCF-7 cells and breast tumor explants. Singh N, Nigam M, Ranjan V, Zaidi D, Garg VK, Sharma S, Chaturvedi R, Shankar R, Kumar S, Sharma R, Mitra K, Balapure AK, Rath SK. Cancer Sci; 2011 May 18; 102(5):1059-67. PubMed ID: 21276137 [Abstract] [Full Text] [Related]
37. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis. Khan S, Shukla S, Farhan M, Sinha S, Lakra AD, Penta D, Kannan A, Meeran SM. Life Sci; 2020 Sep 01; 256():117976. PubMed ID: 32561397 [Abstract] [Full Text] [Related]
38. [The inhibitory effects of tamoxifen on glioma cells SHG-44]. Wang S, Jiao BH. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Feb 01; 25(1):111-2, 144. PubMed ID: 21186631 [No Abstract] [Full Text] [Related]
39. [Effect of xy2004, a centchroman derivative, on proliferation of MCF-7 cells in vitro and the mechanism]. Hou J, Li P, Zeng J, Xu X, Xiong X, Mi M. Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct 01; 34(10):1511-4. PubMed ID: 25345952 [Abstract] [Full Text] [Related]
40. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Singh MM. Med Res Rev; 2001 Jul 01; 21(4):302-47. PubMed ID: 11410933 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]